Wittkopp competitive analysis

Loading summary...

Explore patent oppositions filed by Wittkopp against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025
Processes For Preparing Jak Inhibitors And Related Intermediate CompoundsINCYTEAug 12, 2025
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
Cannabidiol Preparations And Its UsesGW RESEARCHJul 22, 2025
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 18, 2025
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 20, 2025
Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 17, 2025

Latest PTAB cases involving Wittkopp

Discover the latest PTAB cases involving Wittkopp, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wittkopp with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WITTKOPP10 - - -
ASTRAZENECA - 27 - -
BRISTOL MYERS SQUIBB IRELAND - 43 - -
BRISTOL MYERS SQUIBB IRELAND UNLIMITED - 43 - -